BCR-ABL tyrosine kinase inhibitors

APO IMA 400 Pill - orange capsule-shape, 17mm

Pill with imprint APO IMA 400 is Orange, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Apotex Corp.

Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Acute Lymphoblastic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imatinib (Imatinib [ im-ma-ta-nib ])-APO IMA 400-400 mg-Orange-Capsule-shape
Imatinib (Imatinib [ im-ma-ta-nib ])-APO IMA 400-400 mg-Orange-Capsule-shape
Imatinib (Imatinib [ im-ma-ta-nib ])-APO IMA 400-400 mg-Orange-Capsule-shape

Imatinib
Generic Name: imatinib [ im-ma-ta-nib ]
Imprint: APO IMA 400
Strength: 400 mg
Color: Orange
Size: 17.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Silicon dioxide, Crospovidone, Magnesium stearate, Hypromellose 2910 (5 mPa.s), Ferric oxide red, Ferric oxide yellow, Polyethylene glycol 8000,
Latest News
Related Drugs